This presentation will 1) Discuss the differences between end-point and real-time PCR. 2) Describe three different real-time PCR detection technologies. 3) Describe the process of fluorescence resonance energy transfer (FRET).

Speaker: Nicole Robinson, Ph.D., Medical and Scientific Affairs, Roche Diagnostics

Duration: 30 minutes

Credit hours: 1.0

This presentation will 1) Present a concept on the financial viability starting a molecular diagnostics lab testing practice in terms most convincing to CFOs. 2) Determine what molecular tests should be considered based on internal and external factors and how to gain overall organizational support for doing them in-house. 3) Develop and track the information necessary to convince budget makers and key stake holders to expand molecular diagnostics testing over time.

Speaker: Terry Petersen, MST, CLS, BMS, MT(ASCP), Laboratory Director, Kalispell Regional Medical Center, Montana

Duration: 135 minutes

Credit hours: 2.5

This presentation will: Distinguish between end-point and real-time PCR; Comprehend the advantages of molecular diagnostic testing; rapid time to result, tremendous sensitivity; Comprehend the patient impact of using molecular versus traditional diagnostic tests.

Speaker: John Osiecki, Ph.D., Medical and Scientific Affairs, Roche Diagnostics

Duration: 60 minutes

Credit hours: 1.0

At the end of the session, the participant will be able to 1) differentiate between PCR, TMA, SDA, and bDNA amplification technologies, 2) distinguish between end-point and real-time PCR, and 3) comprehend the impact on the laboratory of using an ASR versus an IVD product.

Speaker: Nicole Robinson, Ph.D., Medical and Scientific Affairs, Roche Diagnostics

Duration: 60 minutes

Credit hours: 1.0

This presentation will cover: Regulatory status of molecular products (IVD, ASR, RUO); Review of the Molecular Laboratory Workflow; Establishing the Pillars for assessing performance of a quantitative moleuclar test; Quality Control Measures; Summaries; Resources available.

Speaker: Vivian Cintron, Ph.D., Medical and Scientific Affairs, Roche Diagnostics

Duration: 60 minutes

Credit hours: 1.0

The ability to characterize, recognize and mediate biological risks in the clinical lab is critical. A laboratory employee may have up to an 8000 time greater risk for exposure compared to the general public. This presentation characterizes biological risk agents and identified the various risks in a clinical lab. Appropriate containment strategies for biological risks are reviewed and reinforced in several scenarios.

Speaker: Julia Engstrom-Melnyk, Ph.D., Medical and Scientific Affairs, Roche Diagnostics

Duration: 52 minutes

Credit hours: 1.0